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ABSTRACT 
 
Structural Studies of Phage Lysis Proteins and Their Targets. 
 (August 2011) 
Vladimir Borisovich Kuznetsov, B.S., University of California, Santa Cruz 
Chair of Advisory Committee: Dr. James Sacchettini 
 
Bacteriophages (phages) are viruses that infect bacteria.  The phages that are 
described by this dissertation encompass 2 classes, double-stranded DNA phages and 
single-stranded RNA phages.  While both of these phages infect similar bacteria, they 
have adopted different mechanisms to lyse, or destroy, the cell in order to release phage 
progeny.  dsDNA phages have large genomes (>20 kb) and use multiple lysis proteins 
(holin, endolysin, and spanin complex) to lyse the cell.  ssRNA phages, on the other 
hand, have small genomes (<6 kb) and only encode one lysis protein. 
The two X-ray crystallography projects outlined here deal with the phage 
proteins involved in these lysis mechanisms. 
The project described in the first study deals with the holin (T) and the antiholin 
(RI) of the ds-DNA phage T4, the major players of the lysis inhibition (LIN) 
phenomenon. Crystal structures of the holin and of the holin-antiholin complex are 
presented. The structures provide new molecular level insights into the phenomenon of 
LIN in bacteriophage T4 and the T-even phages in general. 
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 The second investigation describes ongoing efforts at structural characterization 
of A2, the maturation protein of the ssRNA bacteriophage Qβ that inhibits E. coli MurA. 
In addition, the structure of Bacillus subtilis MurA, which is not recognized by A2, is 
presented. The crystal structure of B. subtilis MurA, the first structure of MurA from a 
Gram-positive organism, allows for a direct comparison of Gram-positive and Gram-
negative homologs and for identification of any significant structural differences. The 
more flexible catalytic loop of B. subtilis MurA protrudes farther out compared to the 
loop of E. coli MurA and creates enough hindrance to prevent A2 from establishing 
secure contact points.    
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CHAPTER I 
INTRODUCTION  
 
X-RAY CRYSTALLOGRAPHY 
 
Overview 
 In December 2010, the Protein Data Bank (PDB) reached a new milestone- the 
number of macromolecular structures available in the PDB archive exceeded 70,000. 
The PDB is the single, global archive for information about the 3D structure of 
macromolecules and their complexes, as determined by X-ray crystallography, NMR 
spectroscopy, and cryo-electron microscopy. The number of entries available was only 
seven when the PDB was founded, with great foresight, at the Brookhaven National 
Laboratory in 1971. More than 87% of all structures deposited in the PDB are 
determined by X-ray crystallography. 
 X-ray crystallography is one of the most exciting and influential areas of modern 
biology. The ability of biomolecules to form crystals that are able to diffract the X-rays 
is the foundation of protein crystallography. Bragg’s law, describing the relationship 
between angles and phases of the incident and reflective waves along with the 
interatomic distances in a crystal matrix, allows the reconstruction of a 3D crystal  
 
 
 
____________ 
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structure based on its diffraction data. Modern crystallography has come a long way 
since Max Perutz determined the molecular structure of hemoglobin in 1959. Hundreds 
of laboratories and pharmaceutical companies all over the world use X-ray 
crystallography in their research utilizing the latest technologies from the areas of 
physics, robotics, and computer programming. Thousands of newly solved structures are 
being deposited in the online database RCSB PDB annually. But despite the 
unquestionable progress of the last thirty years, X-ray crystallography remains a very 
labor-intensive process where simple luck still plays a role. There are presently no 
universal rules or guaranties that would yield a well diffracting crystal. Based on 
numerous factors, solving a crystal structure could take anywhere from a few months to 
years of research. The overall process of obtaining a three dimensional model of a 
biomolecule involves a number of steps requiring a certain proficiency in the fields of 
biochemistry, molecular biology, statistical data analysis, and software interfaces. These 
steps include cloning and overexpression of the genes encoding the target proteins, 
crystallization of the purified proteins, data collection and processing, and computer 
modeling. 
  
Cloning and overexpression of proteins 
 A successful crystallization experiment usually requires a substantial amount of 
highly purified material for the initial screening, typically in the range of 10-100 mg. 
The vast majority of protein targets are present in the cell in such miniscule amounts that 
their direct extraction in sufficient amounts is impossible. It is hard to imagine the field 
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of X-ray crystallography to be where it is today without the development of recombinant 
DNA technologies in the 1970s. Using recombinant DNA techniques, microbial cells 
could be engineered to over-produce foreign proteins. A fragment of coding DNA is 
inserted in a bacterial vector under the control of a powerful promoter and the resulting 
plasmid is transformed into a suitable cell line for subsequent over-expression. One of 
the most common plasmids used for overexpression of proteins is the pET family of 
vectors from Novagen based on the T7 promoter-driven system. pET plasmids not only 
allow cloning of genes under the control of a very powerful promoter- T7 RNA 
polymerase, they also give an option to mark a protein with an affinity tag, for example  
a poly-histidine (His6) tag which aids in protein purification. Not all overexpressed 
proteins could be obtained in soluble form. There are different ways to improve the 
solubility of a recombinant protein. Most popular ones include fusing the expressed 
protein with another well-folded soluble protein such as maltose-binding protein (MBP) 
or truncating the protein to relevant sub-domains. Often times slowing the rate of protein 
production by lowering inducer concentration and/or growing the cells at lower 
temperatures (below 25° C) helps correct protein folding resulting in a more soluble 
protein.   
 
Protein purification 
 In general, the purer the protein, the higher are the chances of obtaining a well-
diffracting crystal. Usually, at least a couple of chromatographic steps are necessary to 
achieve the purity of 95% or higher. The first step of any protein purification is the 
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lysing of cells either via ultrasound (sonication), or by applying excessive pressure 
(French pressure cell press). Clarified cell lysate is then applied to an affinity 
chromatography column if the target protein is outfitted with an affinity tag, such as 
His6-tag. It is common to use ion exchange chromatography, which separates 
biomolecules based on their net charge, as an intermediate step in the purification. Size 
exclusion chromatography, which separates proteins by size, is used as the final 
polishing step - to remove remaining impurities and to resolve oligomeric stages of the 
protein. Once the protein is deemed sufficiently pure and homogenous, it is concentrated 
to 10-50 mg/ml; its aliquots may be flash frozen in liquid nitrogen, and stored at -80° C. 
 
Protein crystallization 
 Proteins are challenging molecules to crystallize – they are large, flexible and 
often presented as a non-uniform population in solution. Protein solubility should be 
gradually decreased in a controlled way to induce crystal formation. In a crystallization 
experiment, relatively concentrated protein solution is mixed with reagents called 
precipitants. As precipitating reagent composition is individual for each protein, a large 
number of conditions have to be probed (screened) to find one producing a crystal. A 
typical set of screened conditions includes polymers, salts, and buffers. A small drop of 
protein mixed with precipitation solution is left to gradually concentrate by means of 
various methods: vapor diffusion, dialysis, or micro-batch. The hanging and sitting drop 
vapor diffusion methods are the most popular. To maximize the likelihood of successful 
crystallization, the protein is screened against hundreds of crystallization conditions 
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covering a wide range of pH, chemical species, and concentrations. Well-equipped 
laboratories use robotic setups of nano-drops, such as Mosquito robot, to maximize the 
number of screenings. Once an initial crystallization condition is found, it often needs to 
be optimized in order to improve crystal quality. Optimization is done by screening 
around the conditions- varying protein to precipitant ratios, buffer pH, and temperature 
of crystallization, and by including various additives, for example, detergent in the 
solution.      
 
 Data collection, processing, and model building 
 Protein crystals are soft and fragile, with an average solvent content of 50%. 
They are thus very susceptible to the ionizing radiation of X-rays and have to be 
collected at cryogenic temperature. To prevent ice formation upon flash-freezing a 
cryoprotectant must be used most of the time. Crystallographic data are collected either 
at home using Rigaku or Bruker X-ray diffractometers with Cu rotating anode radiation 
source, or at synchrotrons, the world most powerful sources of coherent X-ray radiation. 
Collecting data at a synchrotron has a number of advantages: the X-ray beam is 
hundreds times more intense than the one on a home source, and the beam is tunable, a 
requirement for crystallographic experiments involving experimental phasing. In the 
data collection experiment only the intensities (amplitudes) of the diffraction are 
captured by a CCD (coupled charge device) or an image plate detector, while the phase 
relations between the reflections are lost. This phenomenon is known in crystallography 
as the phase problem.  
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There are two major avenues for reconstructing the missing phases. If a 
homology model for another protein with at least 40% of sequence identity already 
exists, molecular replacement technique is often enough to produce the initial phases for 
the reconstruction of the electron density. Otherwise, some additional phasing 
experiments must be performed with heavy atoms introduced into crystals. One of the 
most popular experimental phasing techniques relies on anomalous dispersion (SAD or 
MAD) of the so-called “heavy atoms”. One of the most common choices for introducing 
a heavy atom into protein crystal involves replacing methionine residues with seleno-
methionine during protein over-expression. The Se atoms then act as heavy atoms 
covalently incorporated into the protein crystal.  
The collected reflections are first indexed, i.e. crystal symmetry (or, the space 
group of the crystal), and the dimensions of the unit cell are determined. After the data 
are integrated, they are merged to account for any redundancy, and scaled for 
consistency in the intensity. The scaled data set is used to produce the initial phase 
estimates by aforementioned techniques. The inverse Fourier transform is then 
performed to reconstruct the electron density from the diffraction data. 
 Once the electron density map is obtained, a model of the structure is being built 
into it. The model then undergoes multiple cycles of additional rebuilding and 
refinement to achieve the best possible agreement between the observed and calculated 
structure factors. During refinement, the model is subjected to an impressive display of 
validation tools ranging from geometry checks to folding restrictions. The finished 
model is saved as a .pdb file that contains three-dimensional coordinates of all its atoms. 
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All new models are deposited to www.rcsb.org and are available to anyone with an 
Internet access. 
 
BACTERIOPHAGES AND PHAGE LYSIS PROTEINS 
 
Overview 
 Bacterial viruses, or bacteriophages, are the most widely distributed and diverse 
entities in the biosphere. Anywhere in the world where bacteria could survive, 
bacteriophages are present. British scientist Frederik Twort discovered bacteriophages in 
1915. Few years later, in 1917, a French-Canadian microbiologist Felix d’Herelle made 
the same discovery, independently. Since then, bacteriophages have been widely studied 
throughout the world. Scientists working with phage made a number of critical 
discoveries in the area of biology such as the discovery that DNA is the carrier of 
genetic instructions. 
 
Phage lysis proteins and their targets 
The phages that are described by this dissertation encompass 2 classes, double-
stranded DNA phages and single-stranded RNA phages.  While both of these phages 
infect similar bacteria, they have adopted different mechanisms to lyse, or destroy, the 
cell in order to release phage progeny.  dsDNA phages have large genomes (>20 kb) and 
use multiple lysis proteins (holin, endolysin, and spanin complex) to lyse the cell.  
ssRNA phages, on the other hand, have small genomes (<6 kb) and only encode one 
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lysis protein (1). The two X-ray crystallography projects outlined below deal with the 
phage proteins involved in these lysis mechanisms. 
 
Holin and antiholin of phage T4 
The first project deals with the holin (T) and the antiholin (RI) of the ds-DNA 
phage T4, the major players of the lysis inhibition (LIN) phenomenon. Lysis inhibition 
of T4-infected cells is a phenomenon that was identified in the 1940’s and used for the 
discovery of fundamental genetic processes (2). Recently, it has been shown that LIN 
involves an interaction between the periplasmic domains of holin, T, and antiholin, RI of 
T4. Although the structure of a holin has been solved to intermediate resolution by cryo-
EM (3), no atomic resolution structures of holin or antiholin was available. The 
information derived from the crystal structure determination of the antiholin RI, as well 
as the T—RI complex described in Chapter II adds an important tool in understanding 
the process of lysis inhibition (LIN) and of holin-dependent lysis in general. 
  
A2 of phage Qβ and B. subtilis MurA 
The second project, described in Chapter III, outlines an ongoing effort at the 
structural characterization of A2, the maturation protein of the ssRNA bacteriophage Qβ 
that inhibits E. coli MurA, the enzyme which catalyzes the first committed step in the 
cell wall biosynthesis pathway (4).  An atomic resolution structure of the A2—MurA 
complex will further our understanding of the underlying inhibition mechanism and pave 
the way for the design of novel antimicrobial peptides.  
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In addition, the structure of Bacillus subtilis MurA, which is not recognized by 
A2, is analyzed.   It has been recently shown that A2 does not associate with B. subtilis 
MurA in vitro (5). Since the structures of E. coli MurA in both open and closed 
conformations are available, the structure of B. subtilis MurA, the first from a Gram-
positive organism, allows for the direct comparison of Gram-positive and Gram-negative 
homologs and identifies any significant structural differences. It also helps in explaining 
the specificity of A2 against E. coli MurA. 
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CHAPTER II 
STRUCTURAL STUDIES OF T4 LYSIS PROTEINS  
 
BACKGROUND 
  
 Viruses, from the Latin virus meaning poison, are ever-present parasites of 
bacteria, plants, and animals. Viruses are much simpler organisms than cells; technically 
not classified as living, viruses lack the metabolic machinery to reproduce outside their 
host cells. A virus consists of a genome, made of RNA or DNA, stored inside a protein 
or protein-lipid shell called capsid. The shell is necessary to protect the genome during 
the transmission of virus from one host to another. In addition, the shell uses its sensors 
to locate suitable hosts and is responsible for the delivery of the viral genome into the 
host. Bacterial viruses are known as bacteriophages or phages. 
 Enterobacteria phage T4 is a double-stranded DNA phage that infects E. coli 
bacteria. T4 is a myophage; a class of phages characterized by a long contractile tail- the 
most frequent bacteriophage group. While phage Qβ has one of the smallest genomes, 
T4 has one of the largest, 172 kbp, which comprises 102% of the unique region of 169 
kbp (Figure 2.1) (6). Thus, every T4 virion carries dsDNA with a 3.4 kb terminal 
redundancy (7). A sample of T4 DNA molecules is circularly permuted which makes the 
genetic map of T4 circular despite the fact that its genomic DNA is linear. The dsDNA 
chromosome is encased in an icosahedral head that is 115 nm long. T4 is one of the most 
complex viruses; its genome has 274 open reading frames with more than 40 of those  
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Figure 2.1 Structure of bacteriophage T4 (modified from (6)). 
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encoding structural proteins. A unique feature of T4 phage is its DNA composition. The 
DNA has had all of its cytosine residues replaced by hydroxymethylcytosine, which 
serves to inhibit Type I restriction systems of most strains of E. coli. Additionally, T4 is 
one of the largest phages at approximately 90 nm wide and 200 nm long. Phage T4 is 
made up of a prolate head with hemi-icosahedral ends (8) encapsidating the genomic 
DNA, a 100-nm long cocylindrical contractile tail that ends with a 46 nm-diameter 
baseplate (9), and six 145 nm-long fibers that are attached to the baseplate. Tailed 
bacteriophages in general, compared to animal viruses, are extremely efficient in 
infecting the host cells (7). Usually only one phage T4 particle is needed to infect a host 
cell. This high efficiency is attributed to the phage adsorption apparatus, which consists 
of the long tail fibers (LTFs), short tail fibers (STFs), the baseplate, and the contractile 
tail (6).    
T4 bacteriophage initiates interaction with an E. coli cell when the phage tail 
fibers contact a binding site on a surface of the cell.  Adsorption on the bacterial surface 
is crucial for infection. Infection starts when the T4 phage recognizes either the 
lipopolysaccharide cell surface receptors or OMPs of the host with its long tail fibers. 
This still reversible interaction supposedly allows the phage to move about the surface of 
the E. coli bacterium and produces the recognition signal that is eventually transmitted to 
the baseplate through the LTFs (6). The short tail fibers unfold from under the baseplate, 
where they are initially assembled, and bind to the lipopolysaccharide cell surface 
receptors, this time making the adsorption irreversible. Conformation of the baseplate 
changes from hexagonal to star, or open hex, (9), causing the tail sheath to contract 
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irreversibly to 36 nm long down from the original length of 100 nm. The tail tube on the 
other hand does not contract, protruding from the tail sheath and the baseplate, and 
punctures the outer membrane of the cell (10). When it reaches the periplasmic 
peptidoglycan layer of the host cell, the β-helix needle of the phage used to puncture the 
outer membrane dissociates from the tip of the tube activating three lysozyme domains 
(11). The lysozyme domains digest the peptidoglycan layer making penetration of the 
tail tube to the inner membrane of the cell possible. The phage DNA is ejected into the 
host via the tail tube (12). 
Ejection of the phage DNA into the host initiates the lytic cycle.  Phage enzymes 
completely shut down the cell’s own DNA and RNA synthesizing pathways and 
replicate its own genome (7). Aforementioned uniquely decorated phage DNA allows T4 
nucleases to distinguish between its own genomic DNA and that of the host.  The host 
RNA polymerase is used exclusively for T4 transcription (13). Bacteriophage 
components begin to be produced by way of the host’s metabolic machinery in the 
amount sufficient to assemble up to 200 new phage particles (37° C, 25 min.). The 20 or 
so phage are assembled using mononucleotides obtained from the degraded host 
chromosome. Morphogenetic assembly consists of three independent pathways: filled 
head, tail, and LTFs are made separately via ordered pathways (14). The phage DNA is 
packaged into a head in a spindle like fashion by the packaging apparatus powered by 
ATP hydrolysis (15,16). The mature phage particles are assembled inside the host, and at 
25 minutes, the infection ends with the lysis of the host cell. The newly made phage are 
released into the environment.  
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    Bacteriophage T4, like all double-stranded DNA phages, effects host lysis with 
a holin (T), an endolysin (E), and a spanin complex (pseT.3 and pseT.2) (17). Endolysin 
is a term for a class of enzymes whose purpose is to degrade the cell wall. The T4 
endolysin, E is a “true lysozyme”; just like the egg white lysozyme, it hydrolyzes the 
β(1,4)- glycosidic bonds in the murein. The crystal structure of E is known (18). The 
holin is a membrane protein. T and E accumulate in the cytoplasmic membrane and 
cytoplasm, respectively, throughout the period of late gene expression. E accumulates, 
fully folded, but does not act until released into the periplasmic space. At an allele-
specific time, T triggers to disrupt the membrane by creating a large lesion, allowing E 
to enter the periplasm and degrade the murein layer of the cell envelope. It is the holin 
then that determines the precise timing of lysis. The spanin complex tethers the IM and 
OM and serves to disrupt the OM upon degradation of the murein layer (19). 
    T4, like all known T-even phages, exhibit a unique phenomenon when dealing 
with the host cells (20). In single infection, cells lyse after about 25 minutes (LB, 37° C) 
releasing 100-200 new phage per host cell (20). Newly released phage now infect 
surrounding E. coli cells already infected by phage. The process of continuously 
infecting the cell with new phage particles is termed superinfection. In the event 
superinfection happens 3-5 minutes after the original infection, the host becomes lysis 
inhibited. The phenomenon is called lysis inhibition (LIN). The host is not lysed for up 
to several hours. When lysis does occur, the number of new phage accumulated inside a 
single cell could reach a thousand (20). The LIN state is unstable; it requires continuous 
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superinfection to be maintained. LIN state can be reversed by addition of energy poisons 
that cause the collapse of the membrane potential.  
The phenomenon of lysis inhibition results in wild type T4 making small and 
fuzzy edged plaques on agar lawns because the cells on the perimeter of the plaque are 
in continuous state of LIN. This makes it possible to recognize T4 mutants defective in 
LIN since their plaque morphology is different- large and sharp edged (21). Mutants 
defective in LIN became known as T4r, where “r” stands for rapid lysis. Such mutants 
were mapped to multiple T4 loci. The r system was instrumental in elucidating some of 
the most fundamental principles of molecular genetics (22). Eventually, only two genes-   
rI (23) and rV  (24) were found to be required for establishing LIN in all E. coli strains 
K-12, B, and K-12(λ) and for preserving the wild type plaque morphology. rV  was later 
shown to be allelic to t (20), which encodes the holin T. Recently, Ramanculov et al. 
demonstrated that at the molecular level, the LIN phenomenon is due to the inhibition of 
the holin, T, by the antiholin, RI (25).  
    Bacteriophage holins are a diverse group of proteins. T4 holin has an unusual 
topology as compared to holins from other dsDNA phages (Figure 2.2). All other 
characterized holins have either three (e.g. S105 of phage λ, the most widely studied 
holin to date) transmembrane domains (TMDs) and belong to class I, or two (e.g. S2168 
of phage 21) transmembrane domains and belong to class II (17). There have been more 
than fifty unrelated families of holins from class I and class II identified as of 2000. In 
contrast, T has only one TMD and belongs to a unique class III with the N-terminus 
inside and the C-terminus outside of the inner membrane. Holin T, at 218 residues, is  
 16 
  
  
 
 
Figure 2.2 Topology of Class I, II, and III holins. Sequence of phage T4 holin T with the 
single transmembrane domain underlined. 
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also substantially larger than other holins (e.g. the λ holin S105 is only 105 residues). 
The extra mass comes primarily from its large C-terminal periplasmic domain of 163 
residues, whereas other holins have no significant periplasmic component.  
Holes or lesions created by T were visualized by C. Savva and S. Moussa 
(unpublished) using cryo EM methods. To examine the membrane lesions caused by T4 
T, cells expressing the T holin were plunge frozen in liquid ethane and examined by 
cryo-electron microscopy. Approximately 1/3 of the cells observed showed lesions in the 
inner membrane with an average hole diameter of 200 nm. Most cells only exhibited one 
hole. The size and distribution of holes were similar to the ones formed by the lambda 
holin S105 (26). For S105, holin expression alone at near physiological levels leads to 
formation of large membrane lesions that measure an average of 340nm. 1-2 holes per 
cell were observed, but based on the geometrical constraints of viewing a hole of that 
size in the microscope, an average of 2 holes per cell were estimated. Some holes were 
as big as 1 micrometer. The holes were randomly distributed in the cell periphery. 
Tomography of some of the lesions indicated that they were of irregular shape and 
confirmed that the membrane gaps observed in projection were indeed holes rather than 
membrane deformation or invagination. Two possible models were discussed. One 
model, called “the Swiss cheese” model discusses smaller rings making small holes of 
23nm that coalesce into bigger ones (3).  
The second model was proposed by R. White et al. (27). She showed that GFP-
fused holin accumulates in the cell membrane throughout the periphery up until the point 
of triggering and within a minute it forms discrete patches of fluorescence, termed the 
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rafts. She also showed that the protein in the rafts does not move after triggering but is 
mobile before triggering. The A52V mutant of holin S, which is blocked at the dimer 
stage, did not form rafts, whereas the A52G mutant that causes early lysis formed small 
rafts at an earlier time. 
At this point it is impossible to predict whether the Swiss cheese or the rafts 
model will ultimately prevail. Proponents of the raft model argue that it explains how 
mutations in all 3 TMDs of S affect the holin so there must be some interaction on all 
sides of the helices. Also a raft model excludes lipid rather than extrudes it. But some are 
not convinced that the fluorescence data prove the existence of rafts citing inadequate 
resolution of the method. In cryo, the end result could be seen as one that may have 
started off as a raft or as small holes. Correlative cryo-fluorescence and cryo-electron 
microscopy should be able to tell if the rafts correspond to the large holes that were 
observed. Some early experiments by C. Savva (personal communication) suggest that 
they do not correlate, but that could mean the GFP-holin is not a good hole former and 
that is why the holes did not correlate with the fluorescence presence. 
Recently, Tran et al. showed that lysis inhibition requires interaction of the 
periplasmic domains of T and RI (17). 
    The T4 antiholin, RI, is only 97 residues and contains an N-terminal 
hydrophobic domain and the 75-residue periplasmic domain.  RI has two essential 
cysteines in the periplasmic domain that form an intra-disulfide molecular bond. The 
cysteines are conserved for all known antiholins of T-even phages (Figure 2.3). Gene rI  
is served by both early and late promoters (28) while t  is only served by late promoters. 
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The N-terminal sequence of RI comprises a signal anchor release (SAR) domain, which 
anchors RI in the inner membrane but allows its release into the periplasm, without 
proteolytic processing (25). It is thought that the relatively high content of weakly 
hydrophobic and uncharged polar residues in the SAR domain allows it to exit the 
membrane.  Unless the LIN state is established, RI is inactivated and subsequently 
degraded by the periplasmic protease, DegP. The SAR domain of RI has been identified 
as the major determinant of its instability and the target of DegP. Tran et al. showed that 
DegP is required for the rapid turnover of RI (17). The still unidentified signal for LIN 
probably comes from a superinfecting phage since T4 “ghosts”, phages with heads 
emptied of DNA and internal proteins, fail to impose LIN (7). It is thought that small 
cytoplasmic membrane protein Imm (for immunity) produced as early as 1-2 minutes 
after the primary infection prevents any genetic material from the superinfecting phages 
from reaching the cytoplasm. In addition, the spackle protein was shown to play a role in 
changing the cell envelope to offer resistance to superinfecting phage. Both the DNA 
and more than 1000 internal proteins from a superinfecting phage are localized in the 
periplasm and could potentially serve as a signal for lysis inhibition received by RI. One 
of the working theories that the signal is DNA from a superinfecting phage is being 
currently tested by gel shift assays and NMR relaxation techniques by S. Moussa 
(Young lab, unpublished).   
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Figure 2.3 Sequence analysis of RI orthologs (T-even phages). Green indicates all 
match; yellow residues are conserved; blue residues are similar. Secondary structure 
elements are for RI of phage T4 (based on results below). 
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 METHODS 
 
 Overexpression and purification of T4 RI soluble domain (sRI)  
 Full length RI is an unstable protein with the proteolytic half-life of 2-3 minutes 
(25). The SAR domain is a major determinant of RI instability. A truncated allele, srI, 
which encodes the soluble C-terminal domain of RI, was cloned into pET11a vector 
(NEB) (a T7 promoter driven protein expression system). The C-terminal domain of sRI 
has a non-cleavable poly-histidine tag. The periplasmic region of RI contains two 
essential cysteines; hence the use of a cell line that enhances disulfide bond formation in 
the cytoplasm is desirable. Origami2 (DE3) cell line from EMD was determined to be 
suitable by S. Moussa (Young lab). Origami 2 host strains are K-12 derivatives that have 
mutations in both thioredoxin reductase (trxB) and glutathione reductase (gor) genes, 
which greatly enhance disulfide bond formation in the E. coli cytoplasm.  Recently, it 
was shown by S. Moussa that the yield of sRI could be doubled using the Shuffle (DE3) 
cells (NEB) designed with additional properties to enhance the disulfide bond formation 
and proper folding of the target protein.  
The cells were grown in LB (Luria Broth) media by a modified procedure: after 
growing the culture at 37º C to a mid-log phase of O.D.550 0.5-0.6, the flasks were 
transferred to an ice bath and swirled until the internal temperature reached 16º C. The 
flasks then were transferred back into the shaker pre-incubated at 16º C; culture was 
induced with 1mM IPTG, and grown for 18 hours. This low temperature induction 
resulted in >50% soluble protein (data not shown). 
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Figure 2.4 Purification of RI. Superdex 75 size exclusion chromatography of sRI. SDS-
Page gel of the corresponding fractions is shown below (gel courtesy of S. Moussa). 
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The harvested cell pellet was resuspended in 20 mM phosphate buffer (pH 8.0) 
containing 100 mM NaCl and Protease Inhibitor Cocktail Set V (EMD). The cells were 
lysed by two passes through a cooled French pressure cell (Microfluidics M-110P) at 
19000 psi.  sRI was purified on an IMAC column (Talon Co2+ resin, Clontech) followed 
by the Superdex 75 (GE Healthcare) size exclusion chromatography (Figure 2.4). Protein 
was purified as a monodispersed monomeric fraction with purity >95% as judged by 
SDS-PAGE. The final yield was 3.5 mg/liter culture.  The samples were concentrated 
immediately after purification to 10-13 mg/ml, flash frozen in liquid nitrogen without 
any cryoprotection, and stored at -80º C. To produce Se-Met labeled sRI, cells were 
cultured using methionine-free medium supplemented with 50 mg/liter L-Se-Met, and 
the protein was purified using the same protocol as for the native protein. 
Selenomethionine incorporation was confirmed by MALDI-TOF mass spectrometry. 
It is important to acknowledge a significant input on the project from my 
collaborator Samir Moussa from Dr. Ry Young’s laboratory. S. Moussa contributed all 
the molecular biology and genetic experiments, including creation, optimization and 
testing of the recombinant expression vectors, as well as the search for suitable bacterial 
cell lines. S. Moussa was also responsible for all mass spectrometry experiments 
mentioned in this chapter.  In addition, he also helped prepare the recombinant proteins 
and in preparation of several of the crystallization trials, described below. 
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 Crystallization of sRI 
 Initial crystallization screening was done at 16 °C on Phoenix robot (Art Robbins 
Instruments) using the sitting drop vapor diffusion method. Out of more than 700 
crystallization assays screened, the two most promising results came from the in-house 
crystallization screen Adventure Dive. The Adventure series was designed by Inna 
Krieger (Sacchettini lab) to explore the crystallization space not already covered by 
commercial screens. The formulations are rich in additives, which aid in protein 
stabilization and potential crystal making contacts. The pH range of Adventure series is 
broader than the typical commercial matrices. Crystals were optimized in E3 condition 
from Adventure Dive (100 mM Na citrate (pH 4.5), 1M Na acetate, 0.5% Anapoe X114 
detergent). Diffraction quality crystals were grown by combining equal ratios of the 
protein and reservoir solution by a hanging-drop, vapor diffusion method. The 
selenomethionine labeled derivative of sRI was crystallized under similar conditions.  
 
Overexpression and purification of T4 T soluble domain (sT); purification of              
sT--sRI complex 
 sT, the periplasmic domain of T4 holin, T, comprises residues 56-218, with a 
non-cleavable his6-tag at the C-terminal. sT-his was over expressed in E. coli under 
similar conditions to sRI-his. This resulted in a soluble protein that could be purified 
with a Talon (IMAC) resin. However, upon elution the protein oligomerized into a 
translucent jelly-like substance, probably reflecting the natural function of T to 
aggregate. The problem was rectified by S. Moussa who suggested eluting sT-his into 
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fractions containing a molar excess of purified sRI-his. The resulting complex was 
soluble and stable for at least a few days at 4º C. Size exclusion chromatography of the 
mixture on Superdex 75 column produced a significant peak corresponding to sRI—sT 
complex of ~50 kDa, separated from monomeric sRI-his and sT-his (Figure 2.5). The 
sample was concentrated to 8-10 mg/ml, flash frozen in liquid nitrogen, and stored at -
80º C. Doubly (both sRI-his and sT-his) and singly (only sT-his) substituted 
selenomethionine derivatives of the complex were prepared. 
 
 
 
 
 
 
Figure 2.5 Purification of RI-T complex. Superdex 75 size exclusion chromatography of 
sRI-sT complex with corresponding fractions run on SDS-Page (gel courtesy of S. 
Moussa).  
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Crystallization of sRI-sT complex 
 
 Both the native and selenomethionine substituted sRI—sT complexes were 
crystallized. Initial crystallization screening was done at 16 °C by the sitting drop vapor 
diffusion method, using Mosquito (TTP Labtech) and Phoenix (Art Robbins 
Instruments) robots. Crystals of the native complex were grown by mixing 1.0 µl of the 
protein solution (10 mg ml-1 in 20 mM phosphate, pH 8.0, and 100 mM NaCl) and 1.0 µl 
of the reservoir solution (3.2 M NaCl and 0.1M Na acetate trihydrate, pH 4.6).  
Crystallization trials of the Se-Met labeled derivatives with above condition were 
unsuccessful. Crystals of the doubly Se-Met substituted complex were obtained by 
optimizing Index (Hampton Research) condition C8- 1.0 M ammonium sulfate, 0.1 M 
Bis-Tris, pH 5.5, and 1% PEG 3,350.   
 
Data collection and structure determination 
 X-ray diffraction data were collected at 100 K on beamlines 19-ID and 23-ID at 
APS (Argonne National Labs, Chicago, IL). Additionally, Cr edge (λ=2.29 Å) data set of 
the Se-Met derivative of RI was collected at Rigaku America (Woodlands, TX).  
 Crystals of RI were cryoprotected in the reservoir solution supplemented with 
24% (w/v) ethylene glycol. Diffraction data were processed using HKL2000 (HKL 
Research, Inc.). The structure of RI was determined by the SAD method using the 2.5-Å 
resolution data from the Se-Met labeled crystal. All of the potential six selenium atoms 
were located using SHELXD, and positions were further refined by Sharp. Initial 
automated model building was done within PHENIX suite of software programs. The 
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remaining 26% of the model was manually build using COOT and refined with 
PHENIX. Water molecules were manually added during iterative cycles of model 
building and refinement using an Fo-Fc map.   
 Due to extreme fragility of Se-Met crystals of RI-T complex, the cryoprotectant 
(30% ethylene glycol) was added directly to the sitting drop in 1:1 ratio. The 
experimental phases for the selenomethionine incorporated RI-T crystal were obtained 
using single-wavelength anomalous dispersion phasing. The crystal diffracted to a 
resolution of 2.3 Å. Diffraction data was processed using HKL3000. Automated 
structure solution was carried out by the PHENIX AutoSol wizard resulting in 
preliminary model. Model of RI-T was build by PHENIX AutoBuild. The model was 
further manually built using COOT and refined by PHENIX Refine. Water molecules 
were added in a similar fashion to RI model. 
 Data collection and refinement statistics are provided in Tables 2.1 and 2.2. 
Structural figures were prepared using UCSF Chimera. The structural similarity searches 
were made using VAST and DALI servers.  
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Table 2.1   Crystal Data and Refinement Statistics for sRI 
Data Collection Statistics 
wavelength (Å) 
data set 
resolution (Å) 
completeness % (last shell) 
I/σ(I) (last shell) 
no. of unique reflections 
Rsym (%) 
0.97929 
peak 
40.66-2.21 
97.92 (95.1) 
 
 
 
 
 
Refinement Statistics 
unit cell dimensions 
space group 
no. of protomers per asymmetric unit (Z) 
no. of reflections in the working set 
completeness (%) 
Rfactor (%) / Rfree (%) 
no. of protein residues 
no. of solvent molecules 
average B factor for protein (Å) 
rmsd for bond length (Å) 
rmsd for bond angles (deg) 
a=b=49.98 Å, c=118.68 Å 
P 62 2 2  (180) 
1 
4758 
97.9 
22.4 / 25.9 
68 
27 
69 
0.008 
0.988 
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Table 2.2   Crystal Data and Refinement Statistics for sRI-sT Complex 
Data Collection Statistics 
wavelength (Å) 
data set 
resolution (Å) 
completeness % (last shell) 
I/σ(I) (last shell) 
no. of unique reflections                                        
Rsym (%) 
0.97947 
peak 
44.39-2.50 
 99.64 (98.5) 
 
 
11577 
 
 
Refinement Statistics 
unit cell dimensions 
space group 
no. of protomers per asymmetric unit (Z) 
no. of reflections in the working set 
completeness (%) 
Rfactor (%) / Rfree (%) 
no. of protein residues 
no. of solvent molecules 
average B factor for protein (Å) 
rmsd for bond length (Å) 
rmsd for bond angles (deg) 
a=b=120.13 Å, c=85.16 Å 
P 65 2 2   
1 
 
 
19.7 / 23.7 
213 
62 
43.7 
0.009 
1.04 
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RESULTS AND DISCUSSION 
 
  
Overall structure of RI antiholin 
The periplasmic domain of RI antiholin (sRI hereafter), composed of residues 
25-97 with a noncleavable C-terminal (His)6 tag, was over expressed and purified by Co-
chelating affinity column followed by gel filtration. The single crystal of 
selenomethionine-labeled sRI diffracted up to 2.2 Å and the phases of the x-ray crystal 
structure were solved using the SAD method (Table 2.1). The crystal belongs to the 
hexagonal P6222 space group with one protomer molecule in the asymmetric unit. The 
final model was refined with the R factor of 22.4 and Rfree of 25.9 %, contains residues 
26-92 of sRI and 27 water molecules. Residues 24, 25, and 93-97 are not observed in the 
electron density map and therefore omitted from the structure (Figure 2.6). 
The single protomer of the asymmetric unit of sRI consists of three α-helices, 
exhibiting a long and kinked H1-H2 helix (Residues 28-44 and 46-66 respectively) and a 
C-terminal H3 helix (residues 72-90) (Figure 2.6). H2 is kinked with a bent-angle of 15 
degrees at phe45 with reference to the N terminal helix H1. The helix H3 is connected to 
H2 through a hairpin loop, similar to helix-turn-helix structural motifs observed in the 
DNA binding proteins. The RI structure was searched against the Protein Data Bank 
using the DALI server and some notable homologous hits of longer lengths were found.  
The top scoring structures were helical regions of larger proteins of length ranging from 
134-522 that only marginally resembled RI. Therefore, the structure of RI is unique, and 
there are no homologous structures that can give information about the function of RI. 
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Figure 2.6 Overall structure of sRI. Residues are colored according to their B-factors. 
Long alpha helix is kinked at 15° according to HelixAng (ccp4). The angle between H2 
and H3 is 130°. 
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H3 
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Tetrameric assembly of RI is a dimer of dimers 
Although the asymmetric unit of sRI contained only one protomer, a tetrameric 
assembly was clearly visible in the crystal lattice. The tetramer is composed of four 
identical symmetry related subunits as shown in Figure 2.7 (labeled A, B, C and D). The 
tetramer can be discussed as a dimer of dimers (AB dimer and CD dimer) based on the 
proximity of subunits as shown in Figures 2.7 and 2.8.  The nonbonding interactions 
between subunits of AB dimer are visualized in Figure 2.9. In each dimer, sRI packs in a 
head to tail fashion in which helices H2 and H3 of one subunit (head) contacted the H1 
helix (tail) of the other subunit; and vice versa.   The dimer interfaces between chains A 
and B and chains C and D are strong enough to form a stable dimer: the buried surface 
area of the AB or CD dimer interface is 50 %. The free energy of dimer dissociation is 
26.6 kcal/mol, suggested that the dimer is thermodynamically stable and the solvation 
free energy gain upon dimerization is -33.5 Kcal/mol. The amino acid residues of both 
the subunits contribute to several inter subunit interactions, within the dimeric assembly 
of RI. The helices H2 and H3 of the head region of each subunit are held together by 
intra subunit interactions. In addition, the conformation of the loop connecting the 
helices H2-H3 also favors this arrangement. The Cys69 of this loop forms a disulfide 
bond with the Cys75 of the H3 residue to lock itself in one conformation. The head 
region of one subunit, helices H2, H3 and the loop, together form a binding groove for 
the tail region of the next subunit. The dimer interface contains residues that form 
hydrogen bonds and hydrophobic interactions  (Figure 2.8). The side chain atoms of Phe 
 33 
30, Phe 33, Met 34, Ile 38, Val 41, Leu 44 and Phe 45, all from the N-terminal tail (H1 
helix) of RI are involved in inter subunit hydrophobic interactions with the binding 
 
 
 
 
 
 
 
 
Figure 2.7 Tetrameric assembly of RI. Below is the electronegative surface of tetramer. 
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D 
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groove formed by the head portion of the next subunit. In addition, the OD1 atom of 
Asp27 (one subunit) makes a hydrogen bond with the hydroxyl group of the Tyr 64 (next 
subunit, 3.2 Å distance) and OB atom of Ser 36 hydrogen bonds with the main chain 
carbonyl oxygen atom of Ile 76 of the next subunit (at 2.6 Å distance).  
Within the tetramer (ΔG(int) =-87.1 kcal/mol and ΔG(dis)=13.8 kcal/mol) in the 
crystal lattice, the dimers hug each other through several dimer-dimer interactions as 
shown in Figure 2.8. In contrast to the head to tail interaction of the dimer, the dimer – 
dimer interface is mainly formed between the H1-H2 kinked helices of all four subunits. 
The long kinked helices H1-H2 of one subunit run side by side with the H1-H2 region of 
the next subunit (Figure 2.8).  In each of these interfaces, the Tyr42 of one subunit points 
its side chain in to the kink of the next subunit and stacks with the side chain of Tyr42’ 
of the next subunit. The side chain hydroxyl group of Tyr42 of one subunit also 
hydrogen bonds with the main chain carbonyl atom of Tyr42’ of the next subunit.       
Therefore, it is possible that sRI could exist as a dimer and/or a dimer-dimer. The 
gel filtration profile of RI showed one major peak near 8 KDa and a minor peak near 16 
KDa suggesting RI could predominantly exist as a monomer in solution. However, a 
compact oligomeric assembly like RI might migrate in the smaller molecular weight 
range compared to other globular proteins. Further, the complementarity between inter 
subunit head-tail interactions suggest that the RI molecules should have a natural 
propensity towards a more stable dimer or tetramer form. It is possible that the simple  
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Figure 2.8 Tetrameric assembly of RI as a dimer of dimers. Second dimer is represented 
by filled model for clarity. Below is stereo close up of aromatic stacking interactions 
between the dimers. 
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Figure 2.9 RI AB dimer interactions. 2D representation of all non-bonding interactions 
between RI subunits of dimer AB (GraLab). 
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three helices architecture of the RI and their oligomerization propensity might play a role 
in regulating its binding to T, the anti holin (vide infra). The structure of RI by itself 
leads us to an important question, which oligomeric form of RI can bind to T4 holin T. 
 
sRI-sT complex  
LIN requires the interactions of the periplasmic domains of the holin T and the 
antiholin RI. We have used the truncated proteins for the complex formation, without 
their N-terminal trans membrane regions. Even the truncated T showed a tendency of 
polymerization and aggregation, similar to full length T. The aggregation of T was 
prevented, by eluting the protein directly in to two-fold molar excess of purified RI, 
through the RI-T complex formation. The complex formation was further confirmed by 
gel filtration purification, which indicated the presence of RI-T complex with 2:2 
stoichiometry. It has been shown previously that the periplasmic domain of RI alone is 
sufficient to bind to T and inhibit the holin polymerization. It has also been shown that 
the truncated RI should bind to the periplasmic region of the T. In order to understand 
the structural basis of the holin inhibition mechanism by anti holin (RI), we have 
crystallized the complex between the truncated proteins of RI (residues 25-97, sRI) and 
T (residues 56-218, sT hereafter). The x-ray crystal structure of sRI-sT was solved using 
the SAD method with crystals of selenomethionylated, complexed proteins formed in the 
space group P6522 at 2.6 Å resolution (Table 2.2). One single complex of sRI-sT 
crystallized in the asymmetric unit (see Figure 2.10 for the nomenclature), however a 
thermodynamically stable hetero tetramer was clearly visible in the crystal lattice. 
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Figure 2.10 sRI-sT dimer. Below is stereo close up of the protein-protein interactions. 
  
α1 
β1 
β2 
β3 
β4 
β5 α2 
α3 
N-­‐ter 
C-­‐ter 
LA 
LC 
LE 
H1 
H2 
H3 L1 
β1 
β2 
LA LA 
H1 H1 
P105 
Y42 F111 
R104 
Y57 
I38 
F30 F30 
Y57 Y110 
P105 
F111 
 
R104 
K16
3 
K16
3 
Y110 
Y42 
I38 
K137 K137 
S53 S53 
β1 
β2 
 39 
 
 
 
 
Figure 2.11  sRI-sT interactions. 2D view of non-bonding interactions between sRI and 
sT including hydrogen bonds mediated by water (dark green).  
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Figure 2.12 Ligplot of sRI and sT interactions within the dimer. 
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          The final model was refined with the R factor of 19.8%  and Rfree of 23.8%, contains 
residues 78-218 of sT and residues 26-95 of sRI protomers. Residues 56-77 of sT and 
24, 25, 96, and 97 of sRI are not observed in the electron density map and therefore 
omitted from the structure. 2D display of the binding region between RI and T is shown 
in Figure 2.11 and Figure 2.12. Two subunits of T are in close proximity with the two 
subunits of RI as shown in the figure on page 51 and discussed in later paragraphs. 
    
RI binds to T as a monomer with its tail swapped in to the head 
In contrast to the dimer-dimer assembly of the apo structure, RI molecules in the 
RI-T complex structure exist as monomers. Compared to the tetrameric apo RI subunits, 
the H1 helix of the holo monomeric RI structure undergoes a dramatic movement 
accommodated with some conformational changes in the H1-H2 kink region. In the RI 
holo structure, the helices H2 and H3 (the head region of RI), the disulfide bond between 
the residues Cys69 and Cys75 of this region and the H2-H3 connecting loop all remain 
mostly unchanged upon RI-T complex formation (Figure 2.13). In the RI apo dimer 
structure, the head region of one subunit formed a binding groove between the helices 
H2 and H3 for the accommodation of the H1 tail from the next subunit. In a striking 
contrast, in the holo monomeric structure of RI, the H2-H3 groove of the head region is 
now accommodated with its own H1 tail. The H1 helix of the holo structure undergoes a 
dramatic positional change (maximum displacement of 15 Å) to swing into the H2-H3 
loop region. The H1 tail of the symmetry related subunit of apo RI dimer is now  
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Figure 2.13 Conformational changes in RI. Helix H1 of sRI swoops from the open form 
(RI dimer) shown in purple to the compact monomeric form in green. Below is stereo 
close up. 
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swapped with its own tail region in the holo RI monomers as shown in Figure 2.13. The 
overall conformation of H1 helix of the holo structure remains very similar compared to 
that of the apo RI structure except some local variations in the side chain rotomer 
conformations of residues Met34, Phe45, Phe56, Tyr57 and Tyr86 (Figure 2.13). 
However, the kink region of the holo RI structure near the Phe45 residue undergoes 
significant conformational change to become a loop structure and augments the dramatic 
movement of the tail region. Compared to the apo RI structure, the disulfide bond locked 
H2-loop-H3 head region of the holo RI monomer remains unchanged and its N-terminal 
H1 helix tail swings into its own head (Figure 2.14).                          
 The next important question is that what induces the dramatic movement of this 
H1 helix and monomeric conformation of RI?  Is it possible that the monomeric form of 
RI is induced by its partner protein T? Based on the detailed analysis of RI-T 
interactions (see next paragraph), it appears that the inter protomer contact points do not 
seem to be capable of inducing such a big change in the RI structure. Obviously, if the 
unbound RI can exist only in the tetramer or dimer form, then the oligomer needs to 
dissociate into either the tail extended or compact monomers. It is most likely that the 
free RI molecules can exist as monomers, dimers and tetramers in solution, in 
equilibrium with one another. However, only the monomeric form of RI is capable of 
complex formation with T.  In physiological conditions, the level of overexpression of 
RI and its total concentration in the periplasm should control this equilibrium.  
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Figure 2.14 Stereo overlay of two conformations of sRI. The compact monomeric form 
that binds sT is in blue. Helix H1 has supporting interactions with its own subunit in the 
monomeric form. 
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The structure of sT 
 
The structural fold of the holin was also a complete mystery as its amino acid 
sequence is unique and had no significant match with any protein data bank structures. 
The sRI-sT complex crystal structure presented here also provides the first detailed 
molecular description of the sT protein. The sT structure is composed of a central, 
twisted, antiparallel five-stranded β-sheet formed by β1 - β5 strands, two α  helices on 
one side of this sheet (a N-terminal α1 helix  and a C-terminal α3 helix) and on the 
opposite side is a mixture of loops and a short α-helix, α2. The small loop between β1 
and β2 is labeled LA, β4 and β5 is LD and β5 and α3 is LE. The larger loop between β2 
and α2 is designated LB (residues 119-140), and β3- β4 connecting loop is LC (residues 
143-170). An intra subunit disulfide bond links the Cys175 of β4 strand with the Cys 
205 of the C-terminal helix. 
The sT crystal structure was searched against the protein data bank with VAST 
and DALI servers. Despite a lack of sequence homology to any previously determined 
structure, the sT structure revealed a number of unexpected similarities to several GAF 
domains in its three-dimensional structure (Figure 2.15). The GAF domains (acronym 
derived from first three letters of cGMP-dependent phosphodiesterases (PDEs), 
Anabaena adenylyl cyclases, and E. Coli FhlA proteins) have been discovered in 7400 
different proteins found in all three kingdoms of life. The GAF domains have been 
shown to provide a variety of functions including binding of small molecules, protein-
protein interactions (mostly dimerization) in hundreds of signaling and sensory proteins.  
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Figure 2.15 GAF domain of T. sT is superimposed on GAF domain (light blue) of 
cGMP binding protein (PDB: 2ool). cGMP molecule is represented by light grey surface 
volume. 
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GAF fold is also similar to PAS domains, which are too involved in sensory and 
signaling pathways. 
The common concept among GAF/PAS domains is that they can interact with 
diverse set of small molecule regulators. The putative ligands for many of the GAF/PAS 
containing proteins remain subtle, suggesting that a number of small molecule signaling 
and sensory pathways are yet to be explored. Based on several previously published 
GAF domain crystal structures, that hold the highest structural similarity to sT, the sT 
structure should possess a small molecule-binding pocket between the central beta sheet 
and the loops LB-α2-LC region. This is rather surprising information with respect to the 
holin family of proteins. Closer analysis of this region (Figure 2.15) suggested that the 
loops LB- α2-LC can rearrange themselves to accommodate small molecules like cGMP 
and residues around Glu141, His 145, Asp 136, Phe159, and Tyr191 may play critical 
role in the binding. However, in the current RI inhibited conformation, this region is 
completely buried and not accessible for any small molecule binding. But it seems that 
this region is capable of forming a small molecule-binding pocket by rearranging the LB 
and LC loops, in absence of RI. However, we are not aware of any possibilities of small 
molecule binding to holin proteins. Given the diverse functional background within 
which GAF domains were found, it’s not expected that they all possess identical 
functions. However, for now, we conclude that holin T utilizes GAF fold, an 
evolutionarily adopted signal sensor structure, for its signal transduction function. The 
role of small molecules in the sequence of events of phage lysis in context to GAF like 
holin warrants further investigation.  
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Figure 2.16 Model for holin dimerization. Dimerization could proceed via their α1 and 
α3 helices. Two holins (indicated by Subunit 1 and 2) are superimposed on top of GAF 
dimer (PDB: 2ool).  
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Another important aspect of GAF protein is that it has been shown to regulate 
protein function through dimerization. In this context, based on structural similarity, the 
sT proteins can oligomerize through their α1 and α3 helices. Oligomerization and 
polymerization is the most important aspect of the holin family of proteins, as they need 
to form the lesions in the bacterial cell membranes during the process of phage lysis. 
Figure 2.16 shows the superposition of the sT subdomain of the sRI-sT complex 
structure on top of the GAF dimer (PDB ID: 2ool). In GAF domain, an additional helix 
is also involved in the dimer formation (indicated by an arrow in Figure 2.16), a 3+3 
helix bundle is formed in the dimer interface. The residues 56-77 at the N-teminal of the 
sT subunit are disordered in the crystal structure and the protein was over expressed 
without its transmembrane region. It is likely that, in the absence of anti holin, the holin 
initially forms dimers using a 4 or 6 bundle helices at the interface, similar to many other 
GAF proteins. Interestingly, the sT-sRI complex structure also forms a tetrameric 
assembly as detailed in the next paragraph. However, in the current complex structure, 
the α1-α3 helix region of two sT subunits are moved apart from each other by the 
binding of two RI molecules on either side of the sT-sT contact points (Figure 2.17 and 
next paragraph).   
 
Tetrameric assembly of the sRI-sT complex  
All four subunits are required for the complex formation; the N-terminals of sRI 
and loops LA and LD of sT together form the interface of this hetero complex (Figure 
2.17). This tetrameric assembly (2 sRI and 2 sT) should not be confused for a commonly 
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referred hetero (dimer-dimer), as all four protomers are required for the oligomerization.  
In absence of sRI, the current proximity of sT subunits cannot remain as a stable dimer 
as only small portions of the protomers interact; so is sRI. However, within the tetramer, 
each monomers of sRI forms several non- bonding interactions with both sT molecules, 
on either side of the sT-sT contact points. For the sake of simplicity, we will describe the 
inter protomer interaction on one side of the sT-sT contact point with respect to one 
subunit of sRI; identical interactions are observed on the opposite side of this interface. 
Figure 2.18 depicts the close up of the interacting region between sRI and sT. Each sRI 
molecule within the 2sRI-2sT tetrameric assembly, interacts with both the subunits of sT 
through the network of nonbonding interactions. As shown in Figure 2.17, residues of all 
three sRI helices (the H1-H2-H3 of the compact RI structure, vide ante) are involved in 
the nonbonding interactions with the β1-LA-β2 region and LB loop region of the T 
subunit. The residues Arg104-Phe111 of the sT subunits near the LA loop make many 
interactions, which are critical for the complex formation. The residue Arg104 of β2 of 
sT forms two hydrogen bonds with Ser53 of sRI subunit. The side chain atoms of 
residue Phe105 of sT pack directly into the side chain atoms of Tyr57 of sRI subunit (the 
CG tip of sT-Phe105 is at 4.1-4.2Å distance from the phenyl carbon atoms of sRI-
Tyr57). The residue sT-Leu108 makes hydrophobic interactions with the side chain 
atoms of sRI-Val26 and sRI-Tyr57. The residue sT-Tyr 110 hydrogen bonds with the 
side chain OD1 oxygen atom of the sRI-Asp31 and makes hydrophobic interactions with 
residues sRI-(Phe30, Glu35, Ile38 and Met34). The residue sT-Phe111 points into the 
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hydrophobic pocket formed by residues sRI (Tyr42, I38, S53, Phe56 and Met34) at less 
than 4.5 Å distance. The sT-LB loop adjacent to the β2 strand of sT also makes  
 
 
 
 
 
 
 
 
Figure 2.17 Tetrameric assembly of the holin-antiholin complex. 
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contact with the sRI helices. The residue sT-Pro134 of loop LB is in close proximity 
with the side chain atoms of residues sRI (Ile38, Tyr42 and Met43) to favor hydrophobic 
interactions. The main chain carbonyl atom of sT-Asp136 forms two water mediated 
hydrogen bond interactions with sRI-Glu35. The residue sT-Lys137 forms water 
mediated hydrogen bond interactions with the side chain atoms of sRI-Asp31 and sRI-
Glu35. The sT-Lys163 residue of the loop LC hydrogen bonds with the main chain 
carbonyl oxygen atom of sRI-Met43. All these interactions are depicted in Figure 2.18. 
 The sRI subunit also interacts with the second subunit of sT. The residue sRI-
Asp67 near the end of the helix sRI-H2 salt bridges with the side chain NH1 atom of the 
sT-Arg 212 of the α3 helix. The NZ atom of residue sRI-Lys65 hydrogen bonds with the 
main chain carbonyl oxygen atoms of sT-Arg216 (3.1 Å distance) and sT-Asn179 (3.1 Å 
distance).  Residues Phe178-Tyr184 of the LD loop region of sT subunit also make 
many nonbinding interactions with the sRI subunit. The residues phe178, Leu180, 
Asn182, Ile183 and Tyr184 of sT subunit make hydrophobic interactions with the side 
chain atoms of residues Val26, Asp27, Phe30 and Asn25. Also sT-Asp181 of loop LD 
forms hydrogen bonds with the hydroxyl group of sT-Tyr57 (at 3.2 Å distance) and NH2 
atom of sT-Arg61 (at 3.2 Å distance).  
      In addition to these interactions, the chain carbon atoms Asp181 and Ile183 of 
one subunit of sT protomer contact the Leu108 of the second sT subunit. The residue sT-
Asn107 of loop LA near this contact point is disordered. Therefore, within the sT-sRI 
tetrameric assembly, one subunit of sT contacts the other subunit through the tip of the 
loops LA-LD’ and LD-LA’. These are the only interacting points between the sT  
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Figure 2.18 RI in tetrameric assembly. Stereo close up of antiholin interactions within 
the complex. Each sRI interacts with two holins. 
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subunits. However, each sRI molecule connects both the sT subunits through a network 
of nonbonding interactions, on both sides of the sT-sT contact points to form a stable 
tetramer. As a result, the anti holin RI moves the α1 and α3 helices of two holin subunits 
away from each other by a distance of 28 Å, possibly preventing holin polymerization. 
In absence of anti holin, the α1 and α3 helices of each holin subunit might interact to 
dimerize and then polymerize. The complete mechanism of polymerization needs to be 
explored further.      
 
sRI tetramer is capable of binding DNA 
 Finally, the tetrameric assembly of RI, discussed above, satisfies major criteria of 
a DNA-binding protein: it has a classical helix-turn-helix motif, it satisfies various 
spacial and charge complementarity requirements, and it could fit in the major grooves 
of DNA. The tetramer is predicted to be able to bind a piece of DNA that is at least 30 
bp long. Figure 2.19 displays computer-docking models of two possible ways the 
tetramer could bind DNA.  
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Figure 2.19 DNA binding models. Computer docking of DNA binding by sRI tetramer. 
The top model has a higher predicted probability. 
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Detection of macromolecular assemblies with EBI-MSD service PISA 
 By definition, a macromolecular assembly is a complex of more than one 
polypeptide (or nucleotide) chains that is stable in the native environment. The way the 
chains assemble represents the protein quaternary structure (PQS). Often times, protein 
quaternary structure can be a Biological Unit that performs, in its quaternary state, a 
certain biological function.  
 It is well known that the physiological function of a macromolecular assembly is 
closely related to its 3D structure. Determination of PQS is not trivial. Different 
experimental techniques have been developed to study various properties of 
macromolecular assemblies, but deducing a 3D structure proved to be difficult (29). 
Scattering techniques such as neutron and X-ray could deliver information on the 
chemical composition and possibly multimeric state of the assembly. Dynamic light 
scattering could help to guess a 3D shape from mobility measurements. Electron 
microscopy offers relatively poor resolution and is only suitable to study large 
complexes. Finally, NMR is capable of getting atomic coordinates of macromolecular 
complexes but has limitations on the size of a complex and is not ideal for studying 
protein assemblies.  
 More than 85% of PDB entries are structures solved by means of X-ray 
diffraction on crystals (30). Crystallography is a very special technique in that a protein 
crystal is made up of assemblies. It is expected that PQS makes building blocks for the 
crystal. There is no need to dock subunits to try ascertaining a correct oligomeric 
assembly; the docking is given by crystal structure. Macromolecular interfaces should be 
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viewed as an additional and very important aspect of protein crystallography. The 
problem is to determine a correct oligomeric assembly from a PDB entry.  A PDB file 
contains atomic coordinates of the Asymmetric Unit (ASU). All space symmetry group 
mates of ASU comprise a Unit Cell. Generally speaking, neither ASU nor a Unit Cell 
has any direct relation to the protein quaternary structure. The PQS may be made of a 
single ASU, a part of ASU, several ASU, or even several parts of ASU. 
 Stability of protein complexes depends on properties of protein-protein 
interfaces that include free energy of formation ΔGint, solvation energy gain ΔGs, the 
interface area, hydrogen bonds and salt bridges across the interface, and hydrophobic 
specificity (31). One could view a protein crystal as a packing of assemblies that are 
separated by biologically insignificant contacts, while protein assemblies are made up of 
monomeric units with biologically relevant interfaces between them. The real problem is 
to find a way to separate biologically relevant interfaces from superficial ones caused by 
inter-assembly and crystal packing. 
Over the years a considerable effort has been made in attempts to assess the 
significance of the interface from its properties. Most often used discrimination criterion 
is the interface area, but this does not work for large proteins. Free energy gain of 
interface formation does not consider if energy measure can be uniform for all weights 
and shapes. P-value of hydrophobic patches, which measures probability for the 
interface to be more hydrophobic than found, also does not offer a very high success rate 
of discrimination between monomers and oligomers. Based on empirical evidence, there 
is no ultimate discriminating parameter to identify biologically relevant protein 
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interfaces, even for the dimers (31). Formation of oligomeric complexes is probably a 
collective process that involves a set of interfaces. As such, significance of an interface 
should not be separate from the context of the protein complex. 
PISA (Protein Interfaces, Surfaces and Assemblies) computational server is built 
on principles that it is not the properties of individual interfaces that really matter; it is 
the chemical stability of a protein complex (32). In PISA, macromolecular complexes 
are identified as chemically stable associations. Protein chains will most likely associate 
into largest complexes that remain stable. A protein complex is stable if its free energy 
of dissociation is positive: 
ΔGdiss = -ΔGint –TΔS  > 0, 
Where ΔGint is the enthalpy of engaged interfaces (or the binding energy), T is the 
temperature, and ΔS is the cost in entropy of dissociation. Complexes with positive 
ΔGdiss are considered chemically stable.  
 A multimeric complex may dissociate in different ways and even have more than 
one pattern of dissociation. For example, a homotetramer may dissociate into two dimers 
or four monomers. PISA identifies the preferred dissociation pattern as one with the 
lowest ΔGdiss by analyzing all possible dissociation paths (30). 
 As mentioned earlier, the elongated structure of RI, containing one molecule of 
RI in ASU, was evaluated for probable macromolecular assemblies that would be stable 
in solution with PISA server. Analysis of protein interfaces of RI suggested a 
homotetramer (ΔGdiss =13.8 kcal/mol) dissociating into more stable homodimers 
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 (ΔGdiss =26.6 kcal/mol). Macromolecular assemblies predicted by PISA were visualized 
and appeared to be in good agreement with experimental structures derived from X-ray 
diffraction. 
 
Mechanism of action of antiholin RI resembles that of ecotin 
 Based on the two crystal structures presented above, RI mode of action bears 
striking similarities to the mode of action of another periplasmic protein ecotin.  
 Proteases are often kept from wreaking havoc by binding to proteins that are 
protease inhibitors. Ecotin is a periplasmic protease inhibitor in E. coli that binds to and 
blocks activity of virtually all serine proteases with the canonical Asp-His-Ser triad, 
regardless of the amino acid sequence or substrate specificity. This remarkable extent of 
specificity of inhibition classifies ecotin as a fold-specific inhibitor (33). 
 Ecotin is a 142 amino acid protein with a single disulfide bond that forms a stable 
homodimer of about 16 kDa per subunit (34). The monomer is a single domain made up 
of antiparallel seven-stranded β barrel and loops connecting the secondary structure 
elements. The striking feature of ecotin is its nonglobular shape, with ecotin dimer 
resembling a butterfly (35). The dimer is held together by antiparallel β ribbon 
interactions between the two C-termini in an arm-in-arm fashion. This extensive dimer 
interface characterizes ecotin as a dimer with swapped domains. The notion of domain 
swapping was first introduced by David Eisenberg (36).  The term domain swapped 
means that a segment of one subunit extends a domain that packs into the second 
subunit. The critical element for function of ecotin is that 15 amino acids at the C-
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terminal are packed with the symmetry related subunit (mate). Eisenberg proposed 
domain swap as a possible mechanism for evolution of multimeric proteins from 
monomers. Dimeric ecotin may have evolved from a monomeric inhibitor by domain 
swapping. 
 Ecotin forms a tetrameric complex consisting of two protease molecules and the 
ecotin homodimer in the E2P2 form (Figure 2.20) (37). Ecotin binds in a bidentate 
manner with two surface loop regions that are known as the primary and secondary sites. 
This makes each ecotin molecule to have three protein-protein interaction surfaces. It is 
important to note that each ecotin molecule contacts both of the protease molecules.  
 
 
 
Figure 2.20 Tetramer of ecotin bound to two proteases. Ecotin forms a network complex 
(33). 
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           The primary site of ecotin binds in a manner that resembles a protease substrate  
and forms up to eight main chain hydrogen bonds as a β sheet along the active site cleft. 
Ecotin is a very potent inhibitor due to the primary site loops, but the method of 
inhibition is still not well understood. The secondary site of ecotin is spatially 
independent. The secondary site binds to the protease at the terminal helix over 20 Å 
away from the active site and could form up to five additional hydrogen bonds. The 
binding at the secondary site accounts for the fold specificity of ecotin.  
 Ecotin tetramer could be thought of as a network (38). The advantage of a 
network over a chain is a potential to gain free energy of association through 
cooperativity of the interfaces. A network is potentially much stronger than the sum of 
its constituent parts, while a chain, such as a typical dimer of protease protease-inhibitor 
is only as strong as its weakest link. 
 
All structural homologs of RI form homo oligomers 
The apo RI structure was searched against the Protein Data Bank using the DALI 
server and no direct homologous structures were found. The top scoring structures were 
helical regions of other proteins or parts of helical bundles that only roughly resembled 
RI (Figure 2.21). However, analysis of the top 25 hits revealed important information 
about RI oligomerization. In spite of marginal similarity, all 25 structures formed some 
kind of higher order oligomeric assembly. Apart from DALI search, we also found two 
other homo oligomeric structures similar to apo RI in our literature search (39) (40). 
Interestingly, all these structures utilized their helical region for the homo 
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oligomerization. In general, it’s natural that the free helices in solution can bundle 
together to form higher order oligomers. In case of RI, the elongated apo form should at 
least form a stable dimer in solution as suggested by the crystal structure and DALI 
search results. Therefore the RI should either exist as a higher order oligomer as shown 
in apo RI crystal structure or fold in to a compact monomeric form as observed in the 
RI-T crystal structure.   
 
Modeling RI in the presence of its SAR domain 
  Based on the crystal structure of the periplasmic region of apo RI, it could exist 
as a dimer, tetramer and monomer. The structure is missing the N-terminal region that 
comprises the SAR domain. Within the lipid bilayer, the SAR domain should generally 
span as a single long helix. However, it has been shown in the crystal structure of the 
full-length lysozyme of coliphage 21 (R21) that the SAR domain can undergo a 
conformational change. It folds into two anti-parallel alpha helices once extracted from 
the membrane bilayer, and packs against the C-terminal helical bundle of the enzyme 
(41). In order to visualize various positional possibilities, we modeled the SAR domain 
of the full length RI utilizing the crystallographic coordinates of the first 24 residues of 
R21 enzyme. Figure 2.22 depicts the modeled N-terminal SAR domain of RI subunits in 
a tetramer and dimer (shown as orange ribbon). Within a tetramer, the SAR domain has 
to stay at the periphery near the N-terminals of each subunit; suggesting a somewhat 
restricted movement. As shown in Figure 2.22, within a dimer, the SAR domain can 
either stay at the edge or fold towards the body (as indicated by the black arrow) of the 
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protomer. What is clear from the speculated model is that the oligomerization of RI is 
still possible, even in the presence of SAR domain.  Figure 2.23 depicts possible 
positions of the RI SAR domain, in the RI-T complex structure.    
 
 
 
Figure 2.21 RI structural homologs. Top structural homologs of RI are homo oligomers. 
RI is superimposed on each of the top five structures (magenta helices). Search 
performed with DALI and VAST servers. 
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Figure 2.22 Models of the SAR domain in RI oligomers. RI tetramer (left) and dimer 
(right) with the modeled SAR domains (orange ribbons). Arrow indicates possible 
alternative packing for the SAR domain in RI homo dimer. For visual clarity, only two 
SAR domains are shown for the tetramer of RI. 
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Figure 2.23 Model of the SAR domain of RI in RI-T tetrameric complex. Two SAR 
domains could form a helix bundle at the central contact points. 
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CHAPTER III 
 ANALYSIS OF Qβ A2 AND OF B. subtilis MurA   
 
BACKGROUND 
 
    Lytic bacteriophages are parasitic viruses that infect and replicate inside 
bacteria. Most phages accomplish host lysis using a muralitic enzyme, or endolysin, and 
a holin, which permeabilizes the membrane at a programmed time and thus controls the 
length of the vegetative cycle. By contrast, lytic single-stranded RNA and DNA phages 
accomplish lysis by producing a single lysis protein without muralitic activity (42). 
  The small, single-stranded RNA bacteriophage Qβ has a 4.2 kb nucleotide 
genome (Figure 3.1).  
 
 
 
 
 
 
Figure 3.1 Qβ genome. Linear genome of ssRNA phage Qβ. The gene encoding the 
maturation protein A2 (420 a.a.) is indicated by the shaded box. 
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          The genome contains three cistrons, but encodes four proteins: maturation (A2), coat, 
read-through coat, and replicase (43). Infective Qβ virions are composed of one genomic 
ssRNA molecule encapsulated by 180 copies of a combination of the coat protein and 
read-through protein, and a single copy of A2 (44). Lacking the holin-endolysin 
machinery, Qβ produces only a single gene product to effect lysis. The maturation 
protein A2, which binds the host sex pilus, has a second role as a lysis protein (43). It 
was observed that A2 induction from a plasmid caused cell wall synthesis to cease at 
least 20 minutes prior to lysis (45). The host target of A2 was identified as MurA, an 
enzyme that catalyzes the committed step of murein biosynthesis (45). 
  UDP-N-acetylglucosamine enolpyruvyltransferase (MurA) catalyzes the first 
committed step in the peptidoglycan biosynthesis (Figure 3.2) (46) by transferring the 
enolpyruvyl moiety of phosphoenolpyruvate (PEP) to the 3’-hydroxyl group of UDP-N-
acetylglucosamine (UDP-NAG) (Figure 3.3). The product of this reaction is the 3-
enolpyruvyl ether of enolpyruvyl-UDP-NAG. While most enzymatic reactions utilizing 
PEP as a substrate involve cleavage of the high-energy P—O bond, in this reaction the 
C—O bond of PEP is cleaved to transfer the enolpyruvyl moiety to a second substrate. 
The only other enzyme known to catalyze the transfer of the intact enolpyruvyl moiety 
of PEP to a substrate is 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) (47). 
MurA and EPSPS have a very similar structure despite an amino acid sequence identity 
of only 25% 
The cell wall biosynthesis pathway is not present in humans. For that reason the 
pathway is an attractive pharmaceutical target. MurA is the only enzyme in the pathway   
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Figure 3.2 Cell wall synthesis pathway. A2 (blue square) inhibits enzyme MurA. 
 
 
 
 
 
 
 
 
 
Figure 3.3 Reaction catalyzed by MurA. 
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that is inhibited by fosfomycin, a natural antibiotic (46). 
  From the MurA crystal structures it was concluded that unliganded MurA exists 
in an open conformation (49) (PDB: 1naw) whereas liganded MurA has a more compact 
structure. The enzyme is made up of two globular domains, which are connected by a 
double-stranded hinge. Each domain is roughly spherical with a radius of about 20 Å. 
The main chain of each domain is very similar, with three parallel internal helices 
surrounded by three helices and three four-stranded β-sheets exposed to solvent. There is 
an approximate threefold symmetry, which relates secondary structure elements within 
each of the domains. Multiple forms of Gram-negative MurA have been crystallized to 
date. It was shown that UDP-NAG binding is responsible for the conformational change 
that is required for catalysis to proceed (46). Catalysis is blocked by exclusion of PEP 
from the active site by the covalent bond formation between fosfomycin and residue 
C115 of MurA (50). Mutation of this residue to the aspartic acid residue is the basis for 
fosfomycin resistance of M. tuberculosis (53).  
 
 
 
 
 
 
 
      
 70 
METHODS 
 
Overexpression and purification of Qβ A2 
A2 forms inclusion bodies when overexpressed at 37º C. Previous attempts at 
obtaining purified A2 were concentrated at finding a right detergent system. However, 
recently the soluble and active A2 was purified as a fusion construct MBP-A2. The 93 
kDa fusion protein consists of an N-terminal his-tag, followed by MBP, a short TEV 
cleavage site-containing linker, and A2. Expressed from a plasmid, A2 will lyse E. coli 
cells in about 40 minutes. In order to protect the cells and obtain sufficient yield of the 
protein, MBP-A2 was co-expressed along with B. subtilis MurA. Cold expression at 16º 
C resulted in mostly soluble protein. The complex was purified with amylose resin 
(NEB) yielding 10 mg of protein per liter of media grown. Functionality was determined 
by inhibition of MurA in a phosphate release assay; reaction conditions were previously 
described (54). The inhibition was somewhat lower than that observed by Bernhardt and 
colleagues (45) for an excess of purified phage particles inhibiting MurA in a crude 
lysate. One possibility could be attributed to the steric hindrance of MurA imposed by 
the bulky MPB fusion, as seen elsewhere (55). 
From previous truncation analyses, several lytic fragments of A2 were identified 
(4). The construct of a functional truncation MBP-A2190 (residues 1-190) has been 
purified using the same procedure as for the full-length protein. The yield after 
purification was 0.5 mg per liter culture, significantly lower than that for the full-length 
protein. 
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  To determine the overall structural fold of A2, circular dichroism (CD) was 
performed on equimolar concentrations (2 µM) of MBP-A2, MBP-A2190, and MBP 
(Catrina Reed, unpublished). The CD spectrum of MBP has been published (56), as was 
its crystal structure (57). The results for the percent of alpha-helical content of the MBP 
control (36%) were within error of the published structure (40%). A2 protein’s alpha-
helical content was determined to be about 26% by deconvolution analyses, whereas the 
A2190 truncation was about 36% alpha-helical. Structure analysis (Jpred3) (58) 
predicted that both the full length A2 and A2190 were about one-third alpha-helical. 
 
E. coli MurA-A2 complex 
 Catrina Reed (Young lab) provided in vitro evidence for a direct interaction of 
A2 and MurA with “pull aside” experiments. Amylose magnetic beads were used to 
sequester MBP-A2 to the side of the tube with application of a magnet. MurA associated 
with A2 was eluted in the bound fraction.  The data obtained suggest that MBP-A2 
preferentially binds to both liganded states of MurA, thus a closed conformational state 
of MurA is required for A2 association (Figure 3.4).  
 For TEV cleavage, MBP-A2, TEV, and E. coli MurA with UDP-NAG bound 
were incubated overnight at 4 ºC with no shaking. The mixture was then analyzed for 
soluble and insoluble fractions by Western blotting using antibodies directed against 
either MurA or A2. In the absence of MurA, A2 cleaved from MBP-A2 fusion was 
insoluble; but in the presence of MurA with UDP-NAG, A2 stayed soluble indicating the 
formation of an A2-MurA complex.  
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Figure 3.4 Western blot of MBP-A2/MurA complex. Bound fraction were Western 
blotted with the MurA antibody. MurA bands are visible in UDP-NAG (U) and UDP-
NAG/PEP (U/P) substrate bound fractions (courtesy of C. Reed). 
 
 
            Similar experimental setup using Bacillus subtilis MurA instead of E. coli MurA  
 failed to show that A2  is capable of binding to any form of  Bacillus subtilis MurA. 
Gel exclusion chromatography of the cleavage reaction will be performed to 
purify the complex followed by crystallization experiments. X-ray crystallography will 
be used in the investigation of the MurA—A2 binding interface. 
A fusion construct of the MurA-A2 is being made by C. Reed. It consists of the 
N-terminal his-tag—MurA—a short linker with the TEV site—A2. The idea is to have 
MurA close to the N-terminal (lytic) side of A2. The construct will be assessed for 
expression levels and solubility.  
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The search for soluble lytic truncations of A2 is in progress. Secondary structure 
analysis of A2 predicted two alpha-helical stretches from residues 147-176 and 180-188. 
Functionality of the constructs will be assayed by culture lysis prior to purification. 
Overall protein fold and stability will be verified by SDS-PAGE and CD analyses. 
 Structural studies of a MurA complex with full length A2 or a lytic fragment 
would ultimately provide detailed information about residues involved in binding. From 
these analyses generation of a lytic peptide might lead to the discovery of a novel 
“peptide antibiotic”. 
 
Purification, crystallization and data collection of Bacillus subtilis MurA 
 B. subtilis MurA was over expressed and purified in both the native form and as 
the selenomethionine derivative. pZE12 vector was used for the native overexpression 
after comparing favorably to different pET vectors both in terms of total cell mass 
accumulation and the expression levels. B. subtilis MurA was purified on the Talon 
immobilized metal affinity chromatography (IMAC) column followed by Superdex 75 
size exclusion column. The purity of the protein was above 95% as judged by SDS-
PAGE. MurA was concentrated to 10-12 mg/ml and crystallized using the hanging drop 
vapor diffusion method. Crystals appeared in about 3 days in several PEG 3350 based 
buffer conditions.  
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The native crystal diffracted up to 2.5 Å resolution at the APS 23ID source 
(Argonne Labs, IL). Despite its relatively high homology to either E. coli MurA or 
Enterobacter clocae MurA (around 49%), solving the structure of B. subtilis MurA by 
molecular replacement  (MR) method proved difficult. Attempts were made using 
different models (whole molecules as well as the sub-domains) and different software 
programs including Phaser and MolRep.  
 In order to utilize the single anomalous dispersion (SAD) method, the 
selenomethionine analog of B. subtilis MurA was overexpressed using B834 (DE3) 
(methionine auxotroph) cell line from Novagen in pET11a vector under the T7 promoter. 
The protein was purified as described above. The crystallization conditions were re-
screened against the entire crystallization library, as the original conditions did not 
produce high quality crystals.  Protein was crystallized by the hanging drop method in 
HEPES buffered solution with 20% PEG 2000 and LDAO detergent. The data set was 
collected at the APS source 19ID (Argonne Labs, IL). The crystals diffracted to 2.3 Å 
resolution with unit cell parameters of a=b= 82.16 Å, c= 262.78 Å in tetragonal crystal 
system. Crystallographic data for Se-Met crystal is summarized in Table 3.1. 
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Table 3.1   Crystal Data and Refinement Statistics for B. subtilis MurA 
 
Data Collection Statistics 
wavelength (Å) 
data set 
resolution (Å) 
completeness % (last shell) 
I/σ(I) (last shell) 
no. of unique reflections                                        
Rsym (%) 
0.97929 
peak 
48.43-2.28 
 98.9 (88.6) 
 
 
39799 
 
 
Refinement Statistics 
unit cell dimensions 
space group 
no. of protomers per asymmetric unit (Z) 
no. of reflections in the working set 
completeness (%) 
Rfactor (%) / Rfree (%) 
no. of protein residues 
no. of solvent molecules 
average B factor for protein (Å) 
rmsd for bond length (Å) 
rmsd for bond angles (deg) 
a=b=82.161 Å, c=262.783 Å 
P 43 21 2 
2 
 
94.19 
23.6 / 27.6 
834 
135 
60 
0.009 
1.63 
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RESULTS AND DISCUSSION 
 
 
 
The UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) is an essential 
enzyme in the biosynthesis of the peptidoglycan layer of the bacterial cell wall. MurA 
catalyzes the transfer of enolpyruvate from phosphoenolpyruvate to UDP-N-
acetylglucosamine (UNAG) to form enolpyruvyl-UDP-N-acetylglucosamine (EP-NAG), 
the first committed step in the bacterial cell wall synthesis.   Previously published crystal 
structures of MurA revealed that the active site loop can adopt a closed conformation 
upon binding of its substrate UNAG (based on E. coli:UNAG and E. coli:fosfomycyn 
binary complex structures) or an open conformation in the ligand free state (based on 
apo E. Cloacae structure). A2, the maturation protein of bacteriophage Qβ inhibits E.coli 
MurA. Previous studies have suggested that A2 should bind to the closed form of MurA 
and block the substrate access route, possibly by locking the active site loop in the 
closed conformation. Perhaps, A2 can preferably bind only to the substrate bound closed 
form of MurA.  It has also been recently shown that A2 does not associate with B. 
subtilis MurA in vitro even in presence of ligands (5). Since the structures of E. coli 
MurA in the UNAG bound state is available, the structure of B. subtilis MurA (Bs-MurA 
here after), the first structure from a Gram-positive organism, preferably in the closed 
form, allows for the direct comparison between these two homologs.  
To provide further insight in to the molecular basis of A2-MurA interactions, we 
have determined the X-ray crystal structure of Bs-MurA. The structure of Bs-MurA with  
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Figure 3.5 ASU of MurA. Two molecules Bs-MurA in ASU. Region of structural  
 
difference indicated. 
  
Molecule	  A Molecule	  B 
I 
II UNAG 
UNAG PO4 
PO4 
α5 α3 α4 
β7 
UNAG PO4 
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two molecules in the asymmetric unit (molecule A and B) was solved using the SAD 
method with crystals of selenomethionylated protein formed in the space group P43212 at 
2.3-Å resolution. The SAD electron density map was of moderate quality and allowed 
the 60 % of the polypeptide to be traced for both the molecules. Compared to molecule 
B of the asymmetric unit, molecule A contained more disordered electron density 
regions. Several cycles of manual model building guided through the E. coli model, 
SAD experimental map and shake ‘n’ warp averaged map yielded the final model of Bs-
MurA with two molecules in the asymmetric unit as shown in Figure 3.5. Interestingly, 
continuous additional electron density was clearly visible in the active sites of both 
molecules of the asymmetric unit in all stages of refinement, at 1σ cutoff (Figure 3.6). 
This extra electron density, from an unbiased electron density map, was very clear and 
could be readily fitted and refined by the substrate UNAG (Figure 3.6). Significant 
electron density was also visible near the Cys117 residue and could be modeled and 
refined by a phosphate ion, similar to previously observed MurA binary complex 
structures. However, we never included either the UNAG substrate or the phosphate ion 
in our crystallization conditions (see methods section). It is most likely that the enzyme 
captured these ligands during the process of E coli over expression. Further refinement 
after including these molecules yielded the final model with an Rfactor of 23.7% and an 
Rfree of 26.7 % (Table 1). The final model had good stereochemistry for both molecules 
as determined by the Ramachandaran plot. The structure reveals that there is no notable 
difference between two molecules of the asymmetric unit (Figure 3.5). This is illustrated 
in Figure 3.5 (close up), showing the superimposition of the individual molecules. 
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Figure 3.6 Electron density of substrate. Shake’n’warp electron density of UNAG. The 
substrate and phosphate bound in the catalytic cleft shown. 
  
D306 
C117 
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          Molecule A of the asymmetric unit of Bs-MurA superimposes on molecule B with  
an r.m.s.d. of 0.52 Å.  Molecule A showed some differences near the α3 helix compare to 
molecule B, However, the rest of the structure of molecule A including the active site 
loop is very similar to molecule B. We have selected the more ordered molecule, 
molecule B of the Bs-MurA structure for further analysis. 
 
Overall structure of Bs-MurA 
Like the E. coli MurA crystal structure, each subunit of Bs-MurA contains two 
similarly folded globular domains called domain I (residues 21 to 228) and domain II 
(residues 1 to 20 and 230 to 417). The two domains are connected through a double 
linker (β1-α1 and β14-α8) at the inner most part of the active sited. The internal 
arrangement of both the domains is similar with the previously defined “two-α-helix, 
four- β-strand” motif repeated three times around an approximate 3-fold symmetry axis. 
In each domain, three beta sheets form a triangular periphery to capture a bundle of 6 
helices inside. In addition the structure also consists of two small α helices. The 
complete nomenclature is shown in Figure 3.7. 
 
The active site of Bs-MurA 
Each molecule of the Bs-MurA:UNAG binary complex structure contained one 
UNAG molecule, similar to previously observed conformation (coordinates taken from 
PDB ID: 3KQJ). The UNAG binding active site of Bs-MurA is located in a deep pocket 
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between the two domains, enclosed by the β7-α5 connecting loop (referred as active site 
loop in previous publications). Amino acids from both domains contribute to 
 
 
 
 
 
Figure 3.7 Bs-MurA nomenclature (stereo view). 
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ASP 125.B OD1 <-> UD1 950.A N3    2.696 
GLN 126.B N <-> UD1 950.A O4   2.904 
SER 164.B OG <->UD1 950.A O2A    2.791 
VAL 165.B N <-> UD1 950.A O1A    2.733 
GLY 166.B N <-> UD1 950.A O1B    3.082 
UD1 950.A O4' <-> ASP 306.B OD2    3.006 
UD1 950.A O4' <-> ASP 306.B OD1    2.809 
ARG 122.B NH1 <-> UD1 950.A O2B   2.969 
ARG 398.B NH2 <-> PO4 921.A O4    2.731 
ARG 398.B NH1 <-> PO4 921.A O2    2.624 
PO4 921.A O1 <-> ARG 122.B NH2    3.093 
PO4 921.A O3 <-> ARG 93.B NE    2.996 
CYS 117.B SG <-> PO4 921.A O1    2.788 
ARG 332.B NH2 <-> ASP 306.B OD1   2.791 
ARG 332.B NH1 <-> ASP 306.B OD1   2.659 
UD1 950.A O2' <-> SER 121.B O    2.958 
 
 
 
Figure 3.8(A) Binding pocket close up. Interactions of UNAG in the binding pocket 
(stereo view). Hydrogen bond distances (Å) for UNAG interactions with residues of 
MurA given. 
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Figure 3.8(B) Binding pocket close up. UNAG in the binding pocket.  
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Figure 3.9 MurA superposition. Bs-MurA (purple) superimposed over E. Coli MurA 
(PDB: 3KQJ). Both structures have UNAG bound. 
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the binding of UNAG (Figures 3.8A,B and 3.9). The MurA-UNAG interactions for the 
uridine and ribose moieties of UNAG are very similar with E. coli:UNAG binary 
complex structure. The uridinyl ring of UNAG packed against the two hydrophobic 
patches formed by Pro123 on one side and Gln126 (Leu124 in the E. coli structure) on 
the other side. It also forms hydrogen bond with the side chain oxygen atom of Asp125 
and main chain carbonyl oxygen atom of Gln126.  
The ribose moiety of the UNAG forms one hydrogen bond with the main chain 
carbonyl oxygen atom of Val 328 (of β19-α11 connecting loop) and the pyrophosphate 
bridge is involved in hydrogen bonds with the main chain nitrogen atom of Val165 and 
Gly166, the side chain hydroxyl of Ser164, and the side chain NH1 atom of Arg122 (of 
the catalytic loop). The N-acetylglucosamine group (NAG) forms a water mediated 
hydrogen bond with Lys22 and two direct hydrogen bonds with Asp306. Distances of all 
these hydrogen bonds are listed in Figure 3.8A. In addition two hydrogen bonds, 
hydrophobic interactions also play a role in binding of UNAG to Bs-MurA, similar to E. 
coli MurA. Phe329 inserts its side chain close to the NAG moiety to interact with the 
C5’ and C6’ carbon atoms of NAG group. Phe329 also interacts with the C3 carbon 
atom of the ribose group. The terminal C8’ carbon atom of NAG forms hydrophobic 
interactions with the Leu26 residue of Bs-MurA, similar to E. coli MurA. However, the 
Trp residue of E. coli is mutated into Leu97 in Bs-MurA and does not interact with 
UNAG. This Trp to Leu change may be the initiation point for the loop movement 
observed in the Bs-MurA compared to E. coli MurA (see next paragraph, Figure 3.10, 
and next section).   
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Figure 3.10 Loop arrangements. Bs-MurA loop protrudes beyond E. Coli MurA surface.   
UNAG 
PO4	   
(Bs-­‐MurA) 
UNAG 
Active	  site	  loop	   
Of	  Bs-­‐MurA 
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The NH2 atom of Arg122 hydrogen bonds or salt bridges (depending on the 
protonation state of the phosphate ion) to the nearby oxygen atom of a free phosphate 
ion observed near the Cys117 of the active site loop. Like UNAG binding, the presence 
of phosphate ion near the active site is also unexpected, as we never included the ligands 
in the crystallization condition. It is likely that during the overexpression in the E. coli 
cells the Bs-MurA captured the UNAG and the phosphate ion. We also checked the 
possibility of the product EP-UNAG in the place of UNAG and over ruled it based on 
the fit to the electron density map. The free phosphate ion is located 10 Å from the 
UNAG’s pyro phosphate group and make two hydrogen bonds  with the gunadinium 
nitrogen atoms of Arg398 and NE atom of the Arg93 atom. In E. coli, this phosphate 
hydrogen bonds with the tail end of the UNAG substrate, in contrast, it is moved 5 Å 
more towards the active site loop. The active site loop of Bs-MurA, also adopts different 
conformation (Figure 3.8B).  Interestingly, the side chain of Arg93 needs to adopt a 
different conformation compare to that of E. coli MurA to interact with the phosphate 
oxygen atom.  More importantly, the phosphate oxygen atom also coordinates with side 
chain of the highly conserved Cys117. The position of the active site loop, Cys117 and 
the free phosphate ion all are strikingly different compared to that of E. coli binary 
complex structure (Figure 3.8B), while the UNAG position and interacting residues are 
mostly similar.  
The active site loop of Bs-MurA adopts different conformation compare to that 
of E. coli MurA. This conformational change is augmented by several mutations in the  
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Figure 3.11 Mapping of the RAT mutants. Bs-MurA catalytic loop position relative to 
E. coli MurA. RAT mutants shown with corresponding Bs-MurA residues.  
V140	  (L138Q) 
T370	  (T368R) 
I128	   
(I126R) 
V145	  (V143R) 
UNAG 
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sequence of Bs-MurA compare to E. coli MurA, starting from Leu97 (Trp in E. coli) 
(see Figure 3.8B). The overall protein fold of the Bs-MurA is very similar to that of 
E.coli:UNAG complex (with an rms difference of 0.87 Å (for 380 residues) after the 
superposition of the main chain Cα atoms), except the region around the Leu97 residue, 
adjacent α3 helix and the active site loop near α3 helix (Figure 3.10).   
Therefore, it is evident that Bs-MurA:UNAG complex structure adopts a closed 
conformation similar to previous ligand bound MurA structures. However, compared to 
E. coli MurA:UNAG structure, the active site loop of Bs-MurA adopts a new 
conformation augmented by the sequence variation of this Gram-positive protein. A2, the 
maturation protein of bacteriophage Qβ inhibits E.coli MurA. Previous studies have 
suggested that A2 should bind to the closed form of MurA and block the substrate access 
route. However, we have no idea about the structure of A2 or its anchoring points in 
MurA. We compared the ligand bound closed form of Bs-MurA (not recognized by A2) 
crystal structure with the E. coli MurA:UNAG closed form structure (the preferred 
partner of A2). As shown in Figures 3.9, 3.10,and 3.11 the main differences are near the 
active site loop region. The catalytic loop of Bs-MurA protrudes out more compared to 
that of E. coli structure, possibly disrupting the anchoring points for the tight binding of 
A2. It is possible that the extra protrusion blocks the binding of A2 to Bs-MurA. This 
notion is consistent with the fact that mutations in E. coli MurA in this region 
compromise the ability of A2 to inhibit E. coli MurA (Figure 3.11).     
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Electrostatic surface comparison of Bs-MurA and E. coli MurA 
Comparison of electrostatic potential surfaces between Bs-MurA and E. coli 
MurA revealed the following key information (Figure 3.12). The substrate-binding site 
of E. coli MurA is significantly larger than that of Bs-MurA and it exhibits the higher 
positive charge distribution. This is in agreement with the activity assay data, suggesting 
higher enzymatic activity of E. coli MurA. 
 In context of the preferential binding of A2 maturation protein to E. coli MurA, 
the electrostatic surface comparison of the two enzymes possibly offers an additional 
clue. In addition to the active site loop conformation, discussed earlier, the local change 
in the charge distribution near the active site loop and more dominant RAT mutants of E. 
coli MurA (indicated by arrows in Figure 3.12) could potentially play a role in the 
difference of A2 binding.  
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Figure 3.12 Electrostatic surface potential of E. coli MurA and B. subtilis MurA  
 
molecules (APBS server). 
  
E.	  Coli	  	  MurA B.	  subtilis	  MurA 
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CHAPTER IV 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
CHAPTER II SUMMARY AND FUTURE DIRECTIONS  
 
 Periplasmic domains of antiholin RI, and holin T of phage T4 were 
overexpressed. Two atomic-resolution crystal structures were presented: a homo 
oligomeric assembly of RI and an RI-T complex that crystallized as a hetero tetramer. 
Based on the crystal structures, a number of important observations concerning the 
process of lysis inhibition (LIN) and of holin-dependent lysis in general could be made. 
Antiholin RI could exist as a dimer, or even a tetramer, in its extended conformation, 
and as a monomer in its compact form. Helix H1 of RI is domain swapped between the 
monomeric and oligomeric conformations. Only RI monomer is capable of binding the 
holin and, based on the crystal contacts in holin-antiholin complex, RI must be in its 
compact monomeric conformation to bind T. Periplasmic domain of holin T is a GAF 
fold and might be capable of binding a small molecule or nucleotide. RI-T complex is a 
hetero tetramer and each RI contacts both T molecules. Binding of RI separates α1, α3 
helices of T molecules in the complex by 28 Å. In absence of RI, holin T can dimerize 
through its (α1, α3) x2 helical bundle.  
 The crystal structure of antiholin RI shows a homo oligomeric assembly. This 
finding is collaborated by both the computational analysis program PISA and by the 
structural homology search with DALI and VAST databases. Additional experiments 
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can be designed to further test the oligomeric state of RI. Small-angle scattering of X-
rays (SAXS) is an established method for the low-resolution structural characterization 
of biological macromolecules in solution and should be applicable in this case. The 
technique allows one to assess the oligomeric state of the proteins and protein 
complexes. Additional experiments such as analytical ultracentrifugation (AUC) and 
cross-linking can also be designed.  
 As previously mentioned, the periplasmic domain of holin T alone was not 
crystallized so far due to its propensity to oligomerize and precipitate out of solution at 
concentrations usually required for protein crystallization. Since T is a GAF domain and 
there are a number of structures of GAF domains in the PDB, one can design a mutant of 
T to be crystallized as a dimer.  
 The majority of GAF folds are expected to bind small molecules or nucleotides. 
Analysis of the crystal structure of T confirms that T is at least capable of binding a 
small molecule based on loop arrangements and key residues at the catalytic site. A 
number of experiments can be designed to test this. One way is to do a metabolite 
screening to search for a substrate. T could also be designed with a cGMP-binding motif 
at the expected catalytic site. Binding of cGMP would make T resistant to antiholin RI. 
It is known that the periplasm is deficient in small molecules because of the 600 Da 
general OMP porins. If the GAF fold of T does bind a small molecule, it might be 
dNMPs produced from likely degradation of T4 DNA during LIN. 
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CHAPTER III SUMMARY AND FUTURE DIRECTIONS 
 
 Crystal structure of B. subtilis MurA was solved at an atomic resolution. This is 
the first such structure for a MurA from a Gram-positive organism. Since the crystal 
structures of MurA from Gram-negative organisms are already known, this allows for 
the direct comparison of Gram-positive and Gram-negative homologs. The structure of 
B. subtilis MurA was compared to that of E. coli MurA and major structural differences 
were identified.   
 The structure of B. subtilis MurA was evaluated with respect to its ability to 
resist inhibition by A2, the maturation protein of phage Qβ. It appears that the more 
flexible catalytic loop of B. subtilis MurA protrudes farther out compared to the loop of  
E. coli MurA and creates enough hindrance to prevent A2 from establishing secure 
contact points. Also, there is a slight difference in the electronegative surface at the 
expected A2 binding site that could potentially contribute to resistance. 
Crystallization of A2, possibly as a complex with E. coli MurA, remains a 
challenge.  
The original RAT mutant of E. coli MurA, L138Q, could be crystallized and is 
expected to have its catalytic loop protruding similarly to one of B. subtilis MurA.  
V. cholerae MurA, which is very close to E. coli MurA on the phylogenetic tree, 
could also be crystallized. It is expected to be inhibited by A2.  V. cholerae MurA is an 
attractive drug target in light of recent major outbreaks of drug-resistant cholera in the 
world.    
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